Cilostazol and Kidney infection (pyelonephritis) - a phase IV clinical study of FDA data

Summary:

We study 7,434 people who have side effects when taking Cilostazol. Kidney infection (pyelonephritis) is found, especially among people who are male, 60+ old, have been taking the drug for 1 - 6 months, also take Nexium and have Diabetes.

The phase IV clinical study analyzes which people take Cilostazol and have Kidney infection (pyelonephritis). It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

7,434 people reported to have side effects when taking Cilostazol.
Among them, 12 people (0.16%) have Kidney infection (pyelonephritis).

What is Cilostazol?

Cilostazol has active ingredients of cilostazol. It is used in arteriosclerosis of the extremities. Currently, eHealthMe is studying from 7,513 Cilostazol users.

What is Kidney infection (pyelonephritis)?

Kidney infection (pyelonephritis) is found to be associated with 2,027 drugs and 1,433 conditions by eHealthMe. Currently, we are studying 12,253 people who have Kidney infection (pyelonephritis).

Number of Cilostazol and Kidney infection (pyelonephritis) reports submitted per year:

Could Cilostazol cause Kidney infection (pyelonephritis)?

Time on Cilostazol when people have Kidney infection (pyelonephritis) *:

Gender of people who have Kidney infection (pyelonephritis) when taking Cilostazol *:

female: 25 %
male: 75 %

Age of people who have Kidney infection (pyelonephritis) when taking Cilostazol *:

Common drugs people take besides Cilostazol *:

Xarelto: 4 people, 33.33%
Zetia: 4 people, 33.33%
Nexium: 4 people, 33.33%
Parsabiv: 3 people, 25.00%
Calcipotriene And Betamethasone Dipropionate: 2 people, 16.67%
Skyrizi: 2 people, 16.67%
Zoloft: 1 person, 8.33%
Diovan: 1 person, 8.33%
Glucophage: 1 person, 8.33%
Flomax: 1 person, 8.33%

Common side effects people have besides Kidney infection (pyelonephritis) *:

Urinary Tract Infection: 5 people, 41.67%
Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 41.67%
Kidney Stones: 3 people, 25.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 16.67%
Pneumonia: 2 people, 16.67%
Neoplasm Malignant (cancer tumour): 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Bacteraemia (presence of bacteria in the blood): 2 people, 16.67%
Thrombocytopenia (decrease of platelets in blood): 1 person, 8.33%
Diarrhea: 1 person, 8.33%

Common conditions people have *:

Diabetes: 7 people, 58.33%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 3 people, 25.00%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 3 people, 25.00%
Dementia (madness): 2 people, 16.67%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 16.67%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 16.67%
Iron Deficiency Anaemia: 2 people, 16.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 16.67%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 16.67%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cilostazol and have Kidney infection (pyelonephritis)?

Check whether Kidney infection (pyelonephritis) is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Cilostazol side effects by duration, gender and age:

Cilostazol side effects (7,513 reports)

Kidney infection (pyelonephritis) treatments and more:

Kidney infection (pyelonephritis) (12,253 reports)

Common drugs associated with Kidney infection (pyelonephritis):

How the study uses the data?

The study uses data from the FDA. It is based on cilostazol (the active ingredients of Cilostazol) and Cilostazol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.